Implications of measuring Medicare Advantage quality at the contract level: What that means for beneficiary choices and plan payments
The Trump Administration’s First Regulatory Action on Medicare Advantage Omits Some Prior Authorization Guardrails
Policy options to cover anti-obesity drugs: Highlighting the Georgetown policy compendium as a resource
Privatizing Medicare: Challenges and Unanswered Questions about Default Enrollment into Medicare Advantage
Did Changes From the Inflation Reduction Act Affect Medicare Beneficiaries’ Plan Decisions During Open Enrollment? Reflections From Two SHIP Counselors
